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Background: Ventricular assist devices (VADs) are crucial in the management of heart transplant candidates. Determining the optimal timing for 
VAD implantation in this population remains poorly defined. The purpose of this study is to use patient characteristics at the time of listing to predict 
30-day survival without the need for a VAD.
Methods: Institutional data was combined with data provided by UNOS. Analysis included 801 UNOS Status 1B and 2 heart transplant candidates 
(>18 yo) listed between 1/1/01-12/31/07. The primary outcome measure was 30-day survival on the waitlist without a VAD. Kaplan-Meier survival 
analysis was performed where the outcomes of interest was death or need for VAD at < 30 days. Candidates transplanted (n=143, 23.8%) or lost to 
follow-up < 30 days after listing (n=4, 0.66%) were censored. Multivariable analysis was performed to determine predictors of death or need for VAD 
on the waitlist. Model discrimination was assessed by calculating the area under the receiver operating curve (AUC).
Results: Patient characteristics included in the risk score are shown in Table 1. The AUC was 0.850 (0.796-0.903). When divided into quartiles, the 
risk of death or need for a VAD < 30 days was 0.0%, 4.2%, 6.3%, and 25.8%.
Conclusions: Patient characteristics at listing are highly associated with death on the waitlist or need for a VAD at < 30 days. Because variables 
included in this model are relatively constant, our risk score might help guide decisions regarding use of VADs as a bridge to transplant.
Table 1
OR LL UL p-value
Male sex 2.26 1.97 3.55 <0.001
Age > 50 2.32 0.75 7.13 0.14
Ischemic Etiology 0.52 0.23 1.19 0.12
Sev/Morbidly Obese 1.84 0.64 5.32 0.26
Hospitalized 8.04 3.36 19.23 <0.001
ICU 1.85 0.88 3.89 0.11
Cr 2.5/HD 4.55 1.34 15.45 0.02
ICD 1.56 0.79 3.07 0.20
Obese 0.24 0.06 1.00 0.05
